索尔辛通过PI3K通路调节VEGFA/B,促进肝细胞癌的扩散
Huan Zhang1, Shanshan Hu1, Jaceline Gislaine Pires Sanches1
1Department of Pathology and Forensic Medicine, College of Basic Medical Sciences, Dalian Medical University, Dalian, 116044, China.
素 (SRI) 的过度表达与肝细胞癌 (HCC) 的不良结果有关. 通过PI3K/Akt/FOXO1通路调节VEGFA/B,SRI促进HCC的生长,提供了一个新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 肝细胞癌 (HCC) 是一种致命的,高度血管化的恶性瘤.
- 细胞增殖是HCC进展的一个关键因素.
- 确定新的治疗点对于改善HCC患者的治疗结果至关重要.
研究的目的:
- 为了研究素 (SRI) 在肝细胞癌中的作用.
- 阐明SRI影响HCC生长的机制.
- 评估SRI作为HCC的潜在治疗点.
主要方法:
- 西方斑点分析以评估蛋白质表达.
- 使用来自癌症基因组图谱 (TCGA) 的数据.
- 在体外和体内实验来评估SRI对增殖和瘤生长的影响,包括敲击研究.
主要成果:
- 索尔辛 (SRI) 过度表达显示出与HCC的不良结果有很强的关联.
- SRI过度表达促进了HCC细胞在体外的增殖和体内瘤的生长.
- SRI通过PI3K/Akt/FOXO1信号通路调节血管内皮生长因子A (VEGFA) 和血管内皮生长因子B (VEGFB).
结论:
- 通过控制VEGFA/B,SRI显著刺激HCC的生长.
- SRI代表了肝细胞癌的新型治疗标.
- 这项研究为肝癌发生提供了新的见解.
更多相关视频
07:59Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Published on: September 3, 2021
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Hedgehog Signaling Pathway
